---
title: ChemPartner vs Sygnature Discovery
slug_a: chempartner
slug_b: sygnaturediscovery
site: cro
review_signal_gate: closed
canonical_path: /compare/chempartner/sygnaturediscovery
---

# ChemPartner vs Sygnature Discovery

Side-by-side profile data from each company listing on this directory.

## ChemPartner

- Profile: [/companies/chempartner](/companies/chempartner)

ChemPartner — Global preclinical CRO with 20+ years of experience supporting drug discovery through IND submission across small molecules and biologics, with 2,000+ scientists and facilities worldwide.

Services: 29. Modalities: 6. Indications: 3. Locations: 12. Certifications: 2. The strongest documented coverage currently appears in services (29).

### Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- Protein Engineering
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Safety Pharmacology
- Genetic Toxicology
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- GLP Toxicology
- Carcinogenicity Studies
- DART (Reproductive & Developmental Toxicology)
- Specialized & Large-Animal Models
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Flow Cytometry Services
- Regulatory Affairs
- Analytical Method Development & Validation
- ICH Stability Studies
- Translational Research
- Pathology & Histology Services

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- Oligonucleotide
- Peptide

### Indications

- Oncology
- Immunology
- Neurology

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)

## Sygnature Discovery

- Profile: [/companies/sygnaturediscovery](/companies/sygnaturediscovery)

Sygnature Discovery — Sygnature Discovery is an integrated drug discovery contract research organization offering target identification, hit-to-lead, lead optimization, computational design, protein science, and in vivo pharmacology services. The company partners with biotech and pharma clients across the US, Canada, the UK, and Europe.

Services: 9. Modalities: 5. Indications: 4. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (9).

### Services

- Discovery Research
- Target Identification & Validation
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- Protein Engineering
- In Vitro ADME / DMPK
- Preclinical In Vivo Studies
- In Vivo PK / PD Studies
- Bioinformatics & Data Science

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- Peptide

### Indications

- Oncology
- Immunology
- Neurology
- Metabolic

### Phases

- Discovery
- Preclinical (General)

### Sourcing models

- Data not yet provided.